BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7927810)

  • 1. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.
    Engel A; Kern WV; Mürdter G; Kern P
    Infection; 1994; 22(3):160-4. PubMed ID: 7927810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia.
    Engervall P; Andersson B; Björkholm M
    Br J Haematol; 1995 Dec; 91(4):838-45. PubMed ID: 8547127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
    Casey LC; Balk RA; Bone RC
    Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.
    de Bont ES; Martens A; van Raan J; Samson G; Fetter WP; Okken A; de Leij LH
    Pediatr Res; 1993 Apr; 33(4 Pt 1):380-3. PubMed ID: 8479819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.
    Diepold M; Noellke P; Duffner U; Kontny U; Berner R
    BMC Infect Dis; 2008 Mar; 8():28. PubMed ID: 18321393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values.
    Herrmann JL; Blanchard H; Brunengo P; Lagrange PH
    Infection; 1994; 22(5):309-15. PubMed ID: 7531179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
    Engel A; Mack E; Kern P; Kern WV
    Infection; 1998; 26(4):213-21. PubMed ID: 9717678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating interleukin (IL)-1 beta, IL-6 and tumor necrosis factor-alpha in children with febrile infection--a comparison with C-reactive protein.
    Lin SJ; Huang JL
    Asian Pac J Allergy Immunol; 1998; 16(2-3):105-9. PubMed ID: 9876948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients.
    Hynninen M; Valtonen M; Vaara M; Markkanen H; Kuusela P; Saxen H; Takkunen O
    Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1039-45. PubMed ID: 8681977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis.
    Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
    Schönbohn H; Schuler M; Kolbe K; Peschel C; Huber C; Bemb W; Aulitzky WE
    Ann Hematol; 1995 Oct; 71(4):161-8. PubMed ID: 7578521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
    Abrahamsson J; Påhlman M; Mellander L
    Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines value as a sepsis and mortality predictor in elderly patients with fever].
    Martí L; Moreno A; Filella X; Marín JL; Almela M; Benito N; Sánchez M; Gatell JM
    Med Clin (Barc); 2003 Sep; 121(10):361-6. PubMed ID: 14565910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
    Cannon JG; Tompkins RG; Gelfand JA; Michie HR; Stanford GG; van der Meer JW; Endres S; Lonnemann G; Corsetti J; Chernow B
    J Infect Dis; 1990 Jan; 161(1):79-84. PubMed ID: 2295861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome.
    Krakauer T; Leduc JW; Krakauer H
    Viral Immunol; 1995; 8(2):75-9. PubMed ID: 8825292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
    de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
    Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
    Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
    Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma.
    Dosquet C; Schaetz A; Faucher C; Lepage E; Wautier JL; Richard F; Cabane J
    Eur J Cancer; 1994; 30A(2):162-7. PubMed ID: 8155390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.